Bonumose is a startup based in the United States, most recent round Series C.
Bonumose is a company headquartered in the United States. Its most recent tracked round is Series C.
Bonumose develops and commercializes low-glycemic index natural sugars using a proprietary enzymatic process to produce tagatose, a rare sugar substitute with health benefits such as low calories, prebiotic effects, and dental benefits.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.